| Risk | Moderately High |
|---|---|
| Min SIP Amount | Not Supported |
| Expense Ratio | 1.40% |
| NAV | ₹15.46 (27 Oct 2020) |
|---|---|
| Fund Started | 25 Mar 2015 |
| Fund Size | ₹25 Cr |
| Name | Sector | Instrument | % Assets |
|---|---|---|---|
| Reliance Industries Ltd. | Energy | Equity | 10.3% |
| Tube Investments Of India Ltd. | Automobile | Equity | 7.1% |
| Hatsun Agro Products Ltd. | FMCG | Equity | 6.7% |
| Neogen Chemicals Ltd. | Chemicals | Equity | 5.4% |
| HDFC Bank Ltd. | Financial | Equity | 5.1% |
| Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 4.5% |
| Larsen & Toubro Ltd. | Construction | Equity | 4.0% |
| Camlin Fine Sciences Ltd. | Chemicals | Equity | 3.9% |
| Elgi Equipments Ltd. | Engineering | Equity | 3.8% |
| Multi Commodity Exchange India | Financial | Equity | 3.7% |
SBI Long Term Advantage Fund Series II Regular Growth is a Equity Mutual Fund Scheme launched by SBI Mutual Fund. This scheme was made available to investors on 25 Mar 2015. Rama Iyer Srinivasan, Nidhi Chawla is the Current Fund Manager of SBI Long Term Advantage Fund Series II Regular Growth fund.The fund currently has an Asset Under Management(AUM) of ₹25 Cr and the Latest NAV as of 27 Oct 2020 is ₹15.46.
The SBI Long Term Advantage Fund Series II Regular Growth is rated Moderately High risk.
The scheme seeks to generate capital appreciation over a period of ten years by investing predominantly in equity and equity-related instruments of companies along with income tax benefit.